Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Reckitt Benckiser to buy India's Paras Pharma


      British consumer goods company Reckitt Benckiser said on Sunday it agreed to buy privately held Indian firm Paras Pharmaceuticals for Rs 3260 crore (USD 726 mn).

      Paras, which is expected to clock sales of more than Rs 10 crore in 2010, makes several over the counter medications, including Moov pain relief ointment, Krack heel care lotion, and D'Cold cold remedy.

      Private equity firm Actis, which owns 63% of Paras, and the firm's other shareholders have agreed to sell theior stakes in the company. Paras' other shareholders include Sequoia Capital, Paras founder Girish Patel and his family.

      In October, India's Business Standard newspaper reported that GlaxoSmithKline Plc, Sanofi-Aventis, Novartis AG and US based Johnson & Johnson had submitted concrete bids to acquire majority stake in Paras.

      It reported that Japan's Taisho Pharmaceutical had also been expected to join the race.

      Reckitt Benckiser was advised by JP Morgan on the deal. Actis and the other Paras shareholders were advised by Morgan Stanley.

      Dec 14, 2010


      Share this Article!

    Back to top^